Showing results (191-200 of 259) with videos related to
Sort By:
Pageof 26
International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancerC A Mantz, P Song, E Farhangi, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 1990
Beam's eye view based prostate treatment planning: is it useful?N N Low, S Vijayakumar, I Rosenberg, et al.Urology|October 8, 1999
PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after interventionA B Jani, M H Chen, F Vaida, et al.Journal of the National Medical Association|October 29, 2000
Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patientsS O Asbell, K C Raimane, A T Montesano, et al.Clinical and Diagnostic Laboratory Immunology|November 1, 2001
Correlation of CD4(+) T-Cell counts estimated by an immunocapture technique (Capcellia) with viral loads in human immunodeficiency virus-seropositive individualsR Kannangai, S Ramalingam, M V Jesudason, et al.Ecotoxicology and Environmental Safety|February 11, 2014
Ionizing radiation effects on sex steroid hormone levels in serum and milt of freshwater fish Oreochromis mossambicusM Saiyad Musthafa, A Jawahar Ali, T H Mohamed Ahadhu Shareef, et al.Radiology|September 1, 1988
Posterior spinal cord block: a dosimetric studyH C Mota, S Vijayakumar, C Sibata, et al.International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12S Vijayakumar, K Winter, W Sause, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Beam's eye view volumetrics: an aid in rapid treatment plan development and evaluationL C Myrianthopoulos, G T Chen, S Vijayakumar, et al.Radiation Oncology Investigations|February 25, 1999
Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancerL M Chen, L Ignacio, R Jacobs, et al.Pageof 26